In connection with the implementation of the project titled “Development(Description) and development of an innovative solution – a complex, two-component medicinal product in the form of eye drops in a multi-dose package without preservatives, aimed at the treatment of open-angle glaucoma”, funded from the state budget by the Medical Research Agency, Pharmaceutical Works Polpharma S.A., you are kindly requested to submit a bid for the purchase and delivery of reference standards of the active substance – netarsudil dimesylate and R-enantiomer of netarsudil dimesylate.
Details of the price inquiry can be found in the documents attached below.